Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...
Lucid Genomics’ platform supports alignment, phasing, variant annotation, methylation analysis, and visualization tasks designed for PacBio HiFi reads. "Long-read sequencing is unlocking parts of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results